Search results
May 23, 2024 · Tables. Efficacy of Doxycycline as PEP to Prevent Bacterial STIs. Doxycycline Individual Level Harms – Antimicrobial Resistance. Doxycycline Use and Adverse Events. Sources. Provides tables of evidence in the use of Doxycycline Post-Exposure Prophylaxis for bacterial STI prevention.
Oct 25, 2022 · Clinical trials suggest doxyPEP would work to reduce STIs — although it’s only been proven in men who have sex with men. Doxycycline has plenty of street cred in the STI world.
May 23, 2024 · Doxycycline is a broad-spectrum tetracycline, recommended as treatment for chlamydia and syphilis and is not recommended for gonorrhoea due to high levels of resistance.3 Doxycycline for STIs in men who have sex with men: the next steps - The Lancet Infectious Diseases
Jul 13, 2023 · July 13, 2023. Don’t Take Chances: Why Doxycycline is a Great Bet Against STIs. This UCSF professor’s research helped usher in a new, one-dose era in helping to prevent major sexually transmitted infections (STIs). She explains what you need to know about doxy-PEP. By Laura López González.
DoxyPEP is the use of doxycycline for post-exposure prophylaxis to prevent bacterial sexually transmitted infections (STIs). Recent increases in STIs make the use of new approaches to decrease STIs a public health priority in Virginia.
• For chlamydial infections affecting the urethra, rectum, or pharynx, doxycycline, 100 mg orally twice daily for seven days, is most effective. • For gonorrheal infection,...
Apr 12, 2023 · The oral antibiotic doxycycline prevented the acquisition of sexually transmitted infections (STIs) when tested among men who have sex with men (MSM) and transgender women who took the medication within 72 hours of having condomless sex, according to findings published today in the New England Journal of Medicine.
